BGI Genomics Co., Ltd.
SZSE:300676.SZ
46.6 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 4,352.736 | 7,046.132 | 6,766.137 | 8,397.23 | 2,800.412 | 2,536.406 | 2,095.544 | 1,711.498 | 1,318.704 | 1,131.982 | 1,047.381 | 794.839 |
| Kosten van de omzet
| 2,179.031 | 3,357.101 | 2,835.423 | 3,353.046 | 1,300.545 | 1,132.558 | 902.204 | 711.249 | 586.203 | 612.138 | 463.341 | 415.359 |
| Brutowinst
| 2,173.706 | 3,689.031 | 3,930.715 | 5,044.184 | 1,499.867 | 1,403.848 | 1,193.34 | 1,000.25 | 732.5 | 519.844 | 584.039 | 379.481 |
| Brutowinstmarge
| 0.499 | 0.524 | 0.581 | 0.601 | 0.536 | 0.553 | 0.569 | 0.584 | 0.555 | 0.459 | 0.558 | 0.477 |
| Onderzoek- en ontwikkelingskosten
| 528.925 | 535.786 | 487.148 | 619.642 | 317.315 | 260.92 | 174.314 | 176.724 | 101.764 | 130.636 | 50.595 | 39.915 |
| Algemene en administratieve kosten
| 128.58 | 140.85 | 156.787 | 126.248 | 72.59 | 55.658 | 50.216 | 68.811 | 43.375 | 37.674 | 137.948 | 106.074 |
| Verkoop- en marketingkosten
| 1,036.291 | 1,608.668 | 1,238.311 | 1,078.444 | 618.737 | 514.276 | 401.861 | 327.612 | 240.551 | 213.92 | 220.852 | 136.124 |
| Verkoop-, algemene en administratieve kosten
| 1,164.871 | 1,749.518 | 1,395.098 | 1,204.692 | 691.327 | 569.934 | 452.077 | 396.423 | 283.927 | 251.594 | 358.8 | 242.198 |
| Overige kosten
| -35.114 | 151.731 | 200.85 | 406.671 | 87.512 | -3.501 | -7.374 | 29.014 | 25.965 | 22.191 | 6.006 | 1.92 |
| Bedrijfskosten
| 1,939.257 | 2,437.035 | 2,083.096 | 2,231.006 | 1,096.154 | 911.004 | 708.494 | 673.087 | 467.182 | 457.46 | 365.387 | 253.858 |
| Bedrijfsresultaat
| 157.424 | 1,659.187 | 1,822.835 | 2,498.174 | 330.129 | 478.416 | 503.508 | 382.343 | 303.908 | 53.56 | 199.022 | 104.382 |
| Bedrijfsresultaat ratio
| 0.036 | 0.235 | 0.269 | 0.297 | 0.118 | 0.189 | 0.24 | 0.223 | 0.23 | 0.047 | 0.19 | 0.131 |
| Totaal overige inkomsten en kosten netto
| -35.538 | -652.23 | -76.941 | -55.88 | -1.943 | -17.928 | 11.287 | 82.525 | 58.871 | 12.526 | -13.991 | -19.401 |
| Inkomen voor belasting
| 121.887 | 1,006.957 | 1,745.893 | 2,442.294 | 328.185 | 474.916 | 496.133 | 409.687 | 324.19 | 74.909 | 204.661 | 106.221 |
| Inkomen voor belasting ratio
| 0.028 | 0.143 | 0.258 | 0.291 | 0.117 | 0.187 | 0.237 | 0.239 | 0.246 | 0.066 | 0.195 | 0.134 |
| Belastingkosten
| 21.854 | 197.515 | 268.195 | 340.242 | 49.666 | 67.072 | 72.447 | 59.67 | 52.135 | 16.38 | 31.993 | 20.867 |
| Nettowinst
| 92.9 | 802.765 | 1,461.536 | 2,090.285 | 276.334 | 386.646 | 398.092 | 332.691 | 262.1 | 28.121 | 135.881 | 81.734 |
| Nettowinstmarge
| 0.021 | 0.114 | 0.216 | 0.249 | 0.099 | 0.152 | 0.19 | 0.194 | 0.199 | 0.025 | 0.13 | 0.103 |
| WPA (Winst Per Aandeel)
| 0.22 | 1.96 | 3.56 | 5.25 | 0.69 | 0.97 | 1.05 | 0.92 | 0.77 | 0.11 | 1.66 | 1.32 |
| Verwaterde WPA
| 0.22 | 1.96 | 3.55 | 5.24 | 0.69 | 0.97 | 1.05 | 0.92 | 0.77 | 0.11 | 1.66 | 1.32 |
| EBITDA
| 771.8 | 2,112.223 | 2,386.893 | 3,089.205 | 673.441 | 731.877 | 654.081 | 546.744 | 451.003 | 173.803 | 262.265 | 147.007 |
| EBITDA ratio
| 0.177 | 0.3 | 0.353 | 0.368 | 0.24 | 0.289 | 0.312 | 0.319 | 0.342 | 0.154 | 0.25 | 0.185 |